Sort
15,273 grants matching “antimicrobial resistance”
Focused Ultrasound Treatment of Skin and Soft Tissue Abscesses
$698,042Thomas Matula · University Of Washington · R01 · FY2023 · AR
Control of intestinal innate immunity by the commensal microbiota in a model host
$697,858Paula I Watnick · Boston Children'S Hospital · R01 · FY2022 · AI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2
$697,600Christopher Davies · University Of South Alabama · R01 · FY2023 · AI
Integrated genotype-informed single-cell molecular antibacterial susceptibility testing platform for rapid and actionable diagnosis of bacteremia
$697,504Tza-Huei Jeff Wang · Johns Hopkins University · R01 · FY2024 · AI
Longitudinal Study of the Vaginal Microbiome Prior To Incident STI
$697,324Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2018 · AI
A Culture-Free Platform for Rapid Pathogen Identification
$697,239Alon Singer · Helixbind, Inc. · R44 · FY2016 · AI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2
$696,246Christopher Davies · University Of South Alabama · R01 · FY2024 · AI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2
$696,185Christopher Davies · University Of South Alabama · R01 · FY2025 · AI
Dissecting Yersinia Yop Targets in Neutrophils
$696,166Joan C. Mecsas · Tufts University Boston · R01 · FY2025 · AI
Antimicrobial discovery from metabolomics of nematode pathogen interactions
$696,137Dennis H Kim · Massachusetts Institute Of Technology · R01 · FY2014 · AT
The Pathogenesis of Enteric Fever
$695,708Ferric C Fang · University Of Washington · R01 · FY2023 · AI
The Pathogenesis of Enteric Fever
$695,708Ferric C Fang · University Of Washington · R01 · FY2022 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis
$694,605Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Obstetric Pharmacology Research Units Network Center at UTMB-Galveston
$694,343Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2011 · HD
Antibacterial inhibitors of RnpA
$693,668Paul M. Dunman · University Of Rochester · R01 · FY2022 · AI
Clinical Impact of Quinolone-Resistant E.coli carriage
$693,547Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2006 · AI
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
$693,256James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Fitness of gram-negative pathogens during bacteremia
$693,079Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Fitness of gram-negative pathogens during bacteremia
$693,079Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Fitness of gram-negative pathogens during bacteremia
$693,079Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Biochemistry of Bacterial Cell Membranes
$693,008Hiroshi Nikaido · University Of California Berkeley · R01 · FY2010 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$692,603David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Characterization of Mucosal Lymphocytes
$692,573Richard S Blumberg · Brigham And Women'S Hospital · R01 · FY2021 · DK
Characterization of Mucosal Lymphocytes
$692,573Richard S Blumberg · Brigham And Women'S Hospital · R01 · FY2022 · DK
Characterization of Mucosal Lymphocytes
$692,573Richard S Blumberg · Brigham And Women'S Hospital · R01 · FY2020 · DK